Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator
Retroviral vectors are the most efficient means of stable gene delivery to hematopoietic stem cells (HSCs). However, transgene expression from retroviral vectors is frequently subject to the negative influence of chromosomal sequences flanking the site of integration. Toward the development of auton...
Gespeichert in:
Veröffentlicht in: | Blood 2003-06, Vol.101 (12), p.4717-4724 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4724 |
---|---|
container_issue | 12 |
container_start_page | 4717 |
container_title | Blood |
container_volume | 101 |
creator | Ramezani, Ali Hawley, Teresa S. Hawley, Robert G. |
description | Retroviral vectors are the most efficient means of stable gene delivery to hematopoietic stem cells (HSCs). However, transgene expression from retroviral vectors is frequently subject to the negative influence of chromosomal sequences flanking the site of integration. Toward the development of autonomous transgene expression cassettes, we inserted the human interferon-β scaffold attachment region (IFN-SAR) and the chicken β-globin 5′ DNase I hypersensitive site 4 (5′HS4) insulator both separately and together into a series of self-inactivating (SIN) lentiviral vector backbones. Transduced cells of the human CD34+ hematopoietic progenitor line KG1a—pooled populations as well as individual clones harboring single integrants—were analyzed for reporter expression during culture periods of up to 4 months. Vectors carrying both the 5′HS4 insulator and the IFN-SAR consistently outperformed control vectors without inserts as well as vectors carrying either element alone. The performance of a set of vectors containing the murine stem cell virus long terminal repeat as an internal promoter was subsequently assessed during in vitro monocytic differentiation of transduced primary human CD34+ cord blood cells. Similar to what was observed in the KG1a hematopoietic progenitor cell model, optimal reporter expression in primary monocytes was obtained with the vector bearing both regulatory elements. These findings indicate that the 5′HS4/IFN-SAR combination is particularly effective at maintaining open chromatin domains permissive for high-level transgene expression at early and late stages of hematopoietic development, and thus could be of utility in HSC-directed retroviral vector–mediated gene transfer applications. |
doi_str_mv | 10.1182/blood-2002-09-2991 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73364444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120506319</els_id><sourcerecordid>73364444</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-4e5438aa981e22c3fafc643ff30fb2b1e0f26c65522719191b952e3c69e83eb83</originalsourceid><addsrcrecordid>eNp9kc2OFCEUhYnROD2jL-DCsNEdyk8VXSRuzERHk0l0oWtCUZculIYRqE7mQXyReZB5JqnpTmYnLEhuvnMuOQehV4y-Y2zg78eQ0kQ4pZxQRbhS7AnasJ4PpI3oU7ShlErSqS07Q-el_KKUdYL3z9EZ4_0gJes26O93yC7lvYkWCDZxwsU4qLcE4rzOJhwgVn_w2QR8AFtTLtimWI2PPu5wnQHPS5NjH2uzgpwiub_DxRrnUpiwqdXYed9McIadT_FhySqzs7e_IeL7O7ILafSrRVmCaSteoGfOhAIvT-8F-vn504_LL-T629XXy4_XxHZcVtJB34nBGDUw4NwKZ5yVnXBOUDfykQF1XFrZ95xvmWp3VD0HYaWCQcA4iAv09uh7k9OfBUrVe18shGAipKXorRCya6eB_AjanErJ4PRN9nuTbzWjei1DP5Sh1zI0VXoto4len9yXcQ_To-SUfgPenADT8gout8R9eeS6YSsHrhr34chBy-LgIetiPazt-Nwq0VPy__vHP5KsrIs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73364444</pqid></control><display><type>article</type><title>Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ramezani, Ali ; Hawley, Teresa S. ; Hawley, Robert G.</creator><creatorcontrib>Ramezani, Ali ; Hawley, Teresa S. ; Hawley, Robert G.</creatorcontrib><description>Retroviral vectors are the most efficient means of stable gene delivery to hematopoietic stem cells (HSCs). However, transgene expression from retroviral vectors is frequently subject to the negative influence of chromosomal sequences flanking the site of integration. Toward the development of autonomous transgene expression cassettes, we inserted the human interferon-β scaffold attachment region (IFN-SAR) and the chicken β-globin 5′ DNase I hypersensitive site 4 (5′HS4) insulator both separately and together into a series of self-inactivating (SIN) lentiviral vector backbones. Transduced cells of the human CD34+ hematopoietic progenitor line KG1a—pooled populations as well as individual clones harboring single integrants—were analyzed for reporter expression during culture periods of up to 4 months. Vectors carrying both the 5′HS4 insulator and the IFN-SAR consistently outperformed control vectors without inserts as well as vectors carrying either element alone. The performance of a set of vectors containing the murine stem cell virus long terminal repeat as an internal promoter was subsequently assessed during in vitro monocytic differentiation of transduced primary human CD34+ cord blood cells. Similar to what was observed in the KG1a hematopoietic progenitor cell model, optimal reporter expression in primary monocytes was obtained with the vector bearing both regulatory elements. These findings indicate that the 5′HS4/IFN-SAR combination is particularly effective at maintaining open chromatin domains permissive for high-level transgene expression at early and late stages of hematopoietic development, and thus could be of utility in HSC-directed retroviral vector–mediated gene transfer applications.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2002-09-2991</identifier><identifier>PMID: 12586614</identifier><language>eng</language><publisher>Washington, DC: Elsevier Inc</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Antigens, CD34 - analysis ; Applied cell therapy and gene therapy ; Binding Sites ; Biological and medical sciences ; Blotting, Southern ; Cell Differentiation ; Cell Line ; Cells, Cultured ; Chickens ; DNA - analysis ; Erythroid-Specific DNA-Binding Factors ; Fetal Blood - cytology ; Gene Expression ; Genetic Vectors - therapeutic use ; Globins - genetics ; Green Fluorescent Proteins ; Hematopoietic Stem Cells - immunology ; Hematopoietic Stem Cells - metabolism ; Humans ; Insulator Elements - genetics ; Interferon-beta - genetics ; Lentivirus - genetics ; Luminescent Proteins - genetics ; Medical sciences ; Monocytes - metabolism ; Nuclear Matrix-Associated Proteins - genetics ; Nuclear Matrix-Associated Proteins - metabolism ; Peptide Elongation Factor 1 - genetics ; Promoter Regions, Genetic ; Terminal Repeat Sequences ; Transcription Factors - genetics ; Transfection ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><ispartof>Blood, 2003-06, Vol.101 (12), p.4717-4724</ispartof><rights>2003 American Society of Hematology</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-4e5438aa981e22c3fafc643ff30fb2b1e0f26c65522719191b952e3c69e83eb83</citedby><cites>FETCH-LOGICAL-c426t-4e5438aa981e22c3fafc643ff30fb2b1e0f26c65522719191b952e3c69e83eb83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14876829$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12586614$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramezani, Ali</creatorcontrib><creatorcontrib>Hawley, Teresa S.</creatorcontrib><creatorcontrib>Hawley, Robert G.</creatorcontrib><title>Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator</title><title>Blood</title><addtitle>Blood</addtitle><description>Retroviral vectors are the most efficient means of stable gene delivery to hematopoietic stem cells (HSCs). However, transgene expression from retroviral vectors is frequently subject to the negative influence of chromosomal sequences flanking the site of integration. Toward the development of autonomous transgene expression cassettes, we inserted the human interferon-β scaffold attachment region (IFN-SAR) and the chicken β-globin 5′ DNase I hypersensitive site 4 (5′HS4) insulator both separately and together into a series of self-inactivating (SIN) lentiviral vector backbones. Transduced cells of the human CD34+ hematopoietic progenitor line KG1a—pooled populations as well as individual clones harboring single integrants—were analyzed for reporter expression during culture periods of up to 4 months. Vectors carrying both the 5′HS4 insulator and the IFN-SAR consistently outperformed control vectors without inserts as well as vectors carrying either element alone. The performance of a set of vectors containing the murine stem cell virus long terminal repeat as an internal promoter was subsequently assessed during in vitro monocytic differentiation of transduced primary human CD34+ cord blood cells. Similar to what was observed in the KG1a hematopoietic progenitor cell model, optimal reporter expression in primary monocytes was obtained with the vector bearing both regulatory elements. These findings indicate that the 5′HS4/IFN-SAR combination is particularly effective at maintaining open chromatin domains permissive for high-level transgene expression at early and late stages of hematopoietic development, and thus could be of utility in HSC-directed retroviral vector–mediated gene transfer applications.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Antigens, CD34 - analysis</subject><subject>Applied cell therapy and gene therapy</subject><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>Blotting, Southern</subject><subject>Cell Differentiation</subject><subject>Cell Line</subject><subject>Cells, Cultured</subject><subject>Chickens</subject><subject>DNA - analysis</subject><subject>Erythroid-Specific DNA-Binding Factors</subject><subject>Fetal Blood - cytology</subject><subject>Gene Expression</subject><subject>Genetic Vectors - therapeutic use</subject><subject>Globins - genetics</subject><subject>Green Fluorescent Proteins</subject><subject>Hematopoietic Stem Cells - immunology</subject><subject>Hematopoietic Stem Cells - metabolism</subject><subject>Humans</subject><subject>Insulator Elements - genetics</subject><subject>Interferon-beta - genetics</subject><subject>Lentivirus - genetics</subject><subject>Luminescent Proteins - genetics</subject><subject>Medical sciences</subject><subject>Monocytes - metabolism</subject><subject>Nuclear Matrix-Associated Proteins - genetics</subject><subject>Nuclear Matrix-Associated Proteins - metabolism</subject><subject>Peptide Elongation Factor 1 - genetics</subject><subject>Promoter Regions, Genetic</subject><subject>Terminal Repeat Sequences</subject><subject>Transcription Factors - genetics</subject><subject>Transfection</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2OFCEUhYnROD2jL-DCsNEdyk8VXSRuzERHk0l0oWtCUZculIYRqE7mQXyReZB5JqnpTmYnLEhuvnMuOQehV4y-Y2zg78eQ0kQ4pZxQRbhS7AnasJ4PpI3oU7ShlErSqS07Q-el_KKUdYL3z9EZ4_0gJes26O93yC7lvYkWCDZxwsU4qLcE4rzOJhwgVn_w2QR8AFtTLtimWI2PPu5wnQHPS5NjH2uzgpwiub_DxRrnUpiwqdXYed9McIadT_FhySqzs7e_IeL7O7ILafSrRVmCaSteoGfOhAIvT-8F-vn504_LL-T629XXy4_XxHZcVtJB34nBGDUw4NwKZ5yVnXBOUDfykQF1XFrZ95xvmWp3VD0HYaWCQcA4iAv09uh7k9OfBUrVe18shGAipKXorRCya6eB_AjanErJ4PRN9nuTbzWjei1DP5Sh1zI0VXoto4len9yXcQ_To-SUfgPenADT8gout8R9eeS6YSsHrhr34chBy-LgIetiPazt-Nwq0VPy__vHP5KsrIs</recordid><startdate>20030615</startdate><enddate>20030615</enddate><creator>Ramezani, Ali</creator><creator>Hawley, Teresa S.</creator><creator>Hawley, Robert G.</creator><general>Elsevier Inc</general><general>The Americain Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030615</creationdate><title>Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator</title><author>Ramezani, Ali ; Hawley, Teresa S. ; Hawley, Robert G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-4e5438aa981e22c3fafc643ff30fb2b1e0f26c65522719191b952e3c69e83eb83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Antigens, CD34 - analysis</topic><topic>Applied cell therapy and gene therapy</topic><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>Blotting, Southern</topic><topic>Cell Differentiation</topic><topic>Cell Line</topic><topic>Cells, Cultured</topic><topic>Chickens</topic><topic>DNA - analysis</topic><topic>Erythroid-Specific DNA-Binding Factors</topic><topic>Fetal Blood - cytology</topic><topic>Gene Expression</topic><topic>Genetic Vectors - therapeutic use</topic><topic>Globins - genetics</topic><topic>Green Fluorescent Proteins</topic><topic>Hematopoietic Stem Cells - immunology</topic><topic>Hematopoietic Stem Cells - metabolism</topic><topic>Humans</topic><topic>Insulator Elements - genetics</topic><topic>Interferon-beta - genetics</topic><topic>Lentivirus - genetics</topic><topic>Luminescent Proteins - genetics</topic><topic>Medical sciences</topic><topic>Monocytes - metabolism</topic><topic>Nuclear Matrix-Associated Proteins - genetics</topic><topic>Nuclear Matrix-Associated Proteins - metabolism</topic><topic>Peptide Elongation Factor 1 - genetics</topic><topic>Promoter Regions, Genetic</topic><topic>Terminal Repeat Sequences</topic><topic>Transcription Factors - genetics</topic><topic>Transfection</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramezani, Ali</creatorcontrib><creatorcontrib>Hawley, Teresa S.</creatorcontrib><creatorcontrib>Hawley, Robert G.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramezani, Ali</au><au>Hawley, Teresa S.</au><au>Hawley, Robert G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2003-06-15</date><risdate>2003</risdate><volume>101</volume><issue>12</issue><spage>4717</spage><epage>4724</epage><pages>4717-4724</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>Retroviral vectors are the most efficient means of stable gene delivery to hematopoietic stem cells (HSCs). However, transgene expression from retroviral vectors is frequently subject to the negative influence of chromosomal sequences flanking the site of integration. Toward the development of autonomous transgene expression cassettes, we inserted the human interferon-β scaffold attachment region (IFN-SAR) and the chicken β-globin 5′ DNase I hypersensitive site 4 (5′HS4) insulator both separately and together into a series of self-inactivating (SIN) lentiviral vector backbones. Transduced cells of the human CD34+ hematopoietic progenitor line KG1a—pooled populations as well as individual clones harboring single integrants—were analyzed for reporter expression during culture periods of up to 4 months. Vectors carrying both the 5′HS4 insulator and the IFN-SAR consistently outperformed control vectors without inserts as well as vectors carrying either element alone. The performance of a set of vectors containing the murine stem cell virus long terminal repeat as an internal promoter was subsequently assessed during in vitro monocytic differentiation of transduced primary human CD34+ cord blood cells. Similar to what was observed in the KG1a hematopoietic progenitor cell model, optimal reporter expression in primary monocytes was obtained with the vector bearing both regulatory elements. These findings indicate that the 5′HS4/IFN-SAR combination is particularly effective at maintaining open chromatin domains permissive for high-level transgene expression at early and late stages of hematopoietic development, and thus could be of utility in HSC-directed retroviral vector–mediated gene transfer applications.</abstract><cop>Washington, DC</cop><pub>Elsevier Inc</pub><pmid>12586614</pmid><doi>10.1182/blood-2002-09-2991</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-4971 |
ispartof | Blood, 2003-06, Vol.101 (12), p.4717-4724 |
issn | 0006-4971 1528-0020 |
language | eng |
recordid | cdi_proquest_miscellaneous_73364444 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Animals Antigens, CD34 - analysis Applied cell therapy and gene therapy Binding Sites Biological and medical sciences Blotting, Southern Cell Differentiation Cell Line Cells, Cultured Chickens DNA - analysis Erythroid-Specific DNA-Binding Factors Fetal Blood - cytology Gene Expression Genetic Vectors - therapeutic use Globins - genetics Green Fluorescent Proteins Hematopoietic Stem Cells - immunology Hematopoietic Stem Cells - metabolism Humans Insulator Elements - genetics Interferon-beta - genetics Lentivirus - genetics Luminescent Proteins - genetics Medical sciences Monocytes - metabolism Nuclear Matrix-Associated Proteins - genetics Nuclear Matrix-Associated Proteins - metabolism Peptide Elongation Factor 1 - genetics Promoter Regions, Genetic Terminal Repeat Sequences Transcription Factors - genetics Transfection Transfusions. Complications. Transfusion reactions. Cell and gene therapy |
title | Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T13%3A10%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Performance-%20and%20safety-enhanced%20lentiviral%20vectors%20containing%20the%20human%20interferon-%CE%B2%20scaffold%20attachment%20region%20and%20the%20chicken%20%CE%B2-globin%20insulator&rft.jtitle=Blood&rft.au=Ramezani,%20Ali&rft.date=2003-06-15&rft.volume=101&rft.issue=12&rft.spage=4717&rft.epage=4724&rft.pages=4717-4724&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2002-09-2991&rft_dat=%3Cproquest_cross%3E73364444%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73364444&rft_id=info:pmid/12586614&rft_els_id=S0006497120506319&rfr_iscdi=true |